Commitments and contingencies |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Commitments and contingencies | |
| Commitments and contingencies | y6. Commitments and contingencies Contingent payments and license agreements We have certain contractual contingent payments under various merger or license agreements executed between 2019 and 2020 for our legacy therapeutic programs. Since we have discontinued the clinical development of our legacy therapeutic programs, we believe any contractual payments to be paid by us or to be received by us under these agreements are remote. Therefore, as of June 30, 2026, no liabilities or were recorded in the accompanying consolidated financial statements for our legacy therapeutic programs. Legal proceedings From time to time, we may be involved in various claims and legal proceedings arising out of our ordinary course of business. We are not currently a party to any claims or legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business and consolidated financial statements. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. |